Selectis Health (GBCS) Return on Capital Employed (2011 - 2025)

Selectis Health has disclosed Return on Capital Employed across 9 years of filings, most recently posting 20.46% for Q4 2025.

• Return on Capital Employed for Q4 2025 came in at 20.46%, down 1684.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 20.46% (down 1684.0% YoY), and the FY2025 annual result was 20.22%, down 1730.0% from the prior year.
• Return on Capital Employed came in at 20.46% for Q4 2025 at Selectis Health, down from 7.25% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 8.64% in Q1 2021 to a low of 38.36% in Q4 2023.
• The 5-year median for Return on Capital Employed is 1.98% (2021), against an average of 9.72%.
• Across the five-year window, Return on Capital Employed plunged 3887 bps in 2023 and surged 4442 bps in 2025, its largest moves.
• Selectis Health's Return on Capital Employed stood at 2.07% in 2021, then surged by 124 bps to 0.51% in 2022, then plunged by 7677 bps to 38.36% in 2023, then soared by 91 bps to 3.62% in 2024, then sank by 465 bps to 20.46% in 2025.
• The last three Return on Capital Employed figures came in at 20.46% (Q4 2025), 7.25% (Q3 2025), and 0.62% (Q2 2025), per Business Quant data.